The value of 18F⁃FDG PET in the diagnosis and differential diagnosis of Parkinson's disease and multiple system atrophy with parkinsonism⁃predominant

The value of 18F⁃FDG PET in the diagnosis and differential diagnosis of Parkinson's disease and multiple system atrophy with parkinsonism⁃predominant

Objective To investigate the value of 18F⁃FDG PET in the diagnosis and differential diagnosis of Parkinson's disease (PD) and multiple system atrophy with parkinsonism⁃predominant (MSA⁃P). Methods Total 96 patients with PD and 52 patients with MSA ⁃ P from The First Hospital of Jilin University...

Full description

Saved in:

Bibliographic Details
Main Authors:	DU Xiao‐xiao, DONG Wan‐hui, LI Yi, SUN Zhi‐hui, FAN Kang‐li, ZHANG Ying
Format:	Article
Language:	English
Published:	Tianjin Huanhu Hospital 2024-12-01
Series:	Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:	parkinson disease multiple system atrophy positron emission tomography computed tomography diagnosis; differential
Online Access:	http://www.cjcnn.org/index.php/cjcnn/article/view/2971
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An Analysis of Age-Related Body Composition Changes and Metabolic Patterns in Korean Adults Using FDG-PET/CT Health Screening Data
by: Chang-Myung Oh, et al.
Published: (2025-01-01)

[18F]FDG PET-Based Radiomics and Machine Learning for the Assessment of Gliomas and Glioblastomas: A Systematic Review
by: Francesco Dondi, et al.
Published: (2025-01-01)

FDG-PET-based brain network analysis: a brief review of metabolic connectivity
by: Pham Minh Tuan, et al.
Published: (2025-01-01)

Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
by: Yong-Jin Park, et al.
Published: (2025-01-01)

Research on the characteristics of 18F-FDG PET/CT in mantle cell lymphoma and the discrimination between cellular morphological variants
by: REN Yixuan, et al.
Published: (2024-12-01)

An ARFID case report assessment with 18F-FDG PET/MRI and treatment with olanzapine, escitalopram and fluoxetine in adult
by: Meichen Liu, et al.
Published: (2025-01-01)

Effectiveness of Contrast Agents and Molecular Indicators in Alzheimer's Diagnosis Through PET and SPECT Imaging on Animal Models
by: Yasaman Abaszadeh, et al.
Published: (2025-01-01)

Role and sensitivity of Positron Emission Tomography with [18F]Fluorodeoxyglucose in diagnosis and follow-up of patients affected by chronic pulmonary aspergillosis (CPA)
by: Gianfranco Schiraldi, et al.
Published: (2018-03-01)

Positron emission tomography molecular imaging for pathological visualization in multiple system atrophy
by: La Dong, et al.
Published: (2025-03-01)

Recent methods for the diagnosis and differentiation of ameloblastoma: a narrative review
by: Ke Hu, et al.
Published: (2024-12-01)

Capecitabine-induced Hand-foot Syndrome with Hyperpigmentation on Oral Mucosa and Nails: A Rare Entity
by: Suprit Malali, et al.
Published: (2025-02-01)

Prospective Study of Dobutamine Stress Echocardiography in Comparison with 18F-fluorodeoxyglucose Positron Emission Tomography for Myocardial Viability in Ischemic Cardiomyopathy
by: Nuthalapati Rama Kumari, et al.
Published: (2024-12-01)

Case report: Detecting giant cell arteritis in [68Ga]Ga-DOTA-Siglec-9-PET/CT
by: Simon M. Petzinna, et al.
Published: (2024-12-01)

Can Radiomics of Dynamic PET Imaging with 11C-methionine Predict EGFR Amplification Status in Glioblastoma?
by: Gleb DANILOV, et al.
Published: (2024-11-01)

Diffused Multi-scale Generative Adversarial Network for low-dose PET images reconstruction
by: Xiang Yu, et al.
Published: (2025-02-01)

Whole-body PET/MRI to detect bone metastases: comparison of the diagnostic performance of the sequences
by: Ulusoy Onur Levent, et al.
Published: (2024-11-01)

Inter-observer variation in gross tumour volume delineation of oesophageal cancer on MR, CT and PET/CT
by: Secerov-Ermenc Ajra, et al.
Published: (2024-10-01)

Gastric Adenocarcinoma Incidentally Detected by PET/CT with PSMA Ligands
by: Cesare Michele Iacovitti, et al.
Published: (2025-01-01)

High-quality 100% Ce3+:(Lu1−xYx)2SiO5 single crystals grown by the hydrothermal technique
by: Encarnación G. Víllora, et al.
Published: (2024-01-01)

Diagnostics of hepatocellular cancer: state-of-the-art
by: T. Yu. Danzanova, et al.
Published: (2014-10-01)

Advances in synaptic PET imaging and intervention with synapse-targeted small-molecular drugs for dementia diagnosis and therapy
by: Xiuhong Lu, et al.
Published: (2025-01-01)

PET in neurotherapeutic discovery and development
by: Melissa Chassé, et al.
Published: (2025-01-01)

Innovative applications and future trends of multiparametric PET in the assessment of immunotherapy efficacy
by: Tingting Qiao, et al.
Published: (2025-01-01)

Terbinafine versus itraconazole: a long-term, randomized, double-blind, clinical trial in chronic pulmonary aspergillosis. A pilote study
by: Gianfranco Schiraldi, et al.
Published: (2016-03-01)

Positron emission tomography tracers for synucleinopathies
by: Jie Xiang, et al.
Published: (2025-01-01)

A generative whole-brain segmentation model for positron emission tomography images
by: Wenbo Li, et al.
Published: (2025-02-01)

Assisted Parkinsonism Diagnosis Using Multimodal MRI—The Role of Clinical Insights
by: Tobias Meindl, et al.
Published: (2025-01-01)

A Peculiar Case of Disseminated Melioidosis with Atypical Features Likely Linked to Bong/Water Pipe Use
by: Kisen Jang, et al.
Published: (2024-12-01)

Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting
by: Martina A. McAteer, et al.
Published: (2025-01-01)

Staging of esophageal cancer using PET/MRI: a systematic review with head-to-head comparison
by: Alisa Mohebbi, et al.
Published: (2025-01-01)

A Laboratory‐Validated, Graph‐Based Flow and Transport Model for Naturally Fractured Media
by: Collin R. Sutton, et al.
Published: (2025-01-01)

Positron emission tomography for phenotyping inflammation of cardiovascular diseases
by: Xiaoyun Luo, et al.
Published: (2024-12-01)

Plasma circulating cell–free DNA integrity and relative telomere length as diagnostic biomarkers for Parkinson’s disease and multiple system atrophy: a cross-sectional study
by: Chao Ying, et al.
Published: (2025-12-01)

Feasibility study of PET/CT for the detection and localization of nervous system damage caused by trimethyltin chloride
by: Anqing Liu, et al.
Published: (2025-01-01)

Retinal optical coherence tomography changes as biomarkers for Parkinsonism duration and severity in the Kashmiri population
by: Irtiqa Mohammad, et al.
Published: (2024-12-01)

Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
by: James A. Wiseman, et al.
Published: (2025-02-01)

The N-acetyltransferase 10 inhibitor [11C]remodelin: synthesis and preliminary positron emission tomography study in mice
by: Rui Luo, et al.
Published: (2025-01-01)

Extrapulmonary sarcoidosis presenting as myositis: A rare case
by: Niraj Bohania, et al.
Published: (2020-01-01)

Dynamics of retinal changes in early-stage Parkinson’s disease
by: Ane Murueta-Goyena, et al.
Published: (2025-01-01)

Editorial: Methods and applications of tumour metabolic imaging in the preclinical and clinical setting
by: Liangjie Lin, et al.
Published: (2025-01-01)